Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTCY NASDAQ:OSRH NASDAQ:POAI NYSE:RVP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTCYBiotricity$0.16-8.8%$0.24$0.15▼$0.75$4.53M1.356,045 shs482,520 shsOSRHOSR$0.51-2.4%$0.54$0.38▼$1.79$18.35M0.8617.94 million shs869,036 shsPOAIPredictive Oncology$4.68-20.0%$3.94$0.71▼$16.54$15.88M1.35473,545 shs441,020 shsRVPRetractable Technologies$0.68+1.6%$0.68$0.60▼$1.14$20.39M1.2559,569 shs99,582 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTCYBiotricity-11.53%-32.70%-31.01%-35.00%-65.92%OSRHOSR-8.30%-7.94%-8.30%+13.73%-55.32%POAIPredictive Oncology0.00%+3.17%+66.19%+139.75%-63.89%RVPRetractable Technologies+4.69%-1.96%0.00%-5.90%-6.94%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTCYBiotricity$0.16-8.8%$0.24$0.15▼$0.75$4.53M1.356,045 shs482,520 shsOSRHOSR$0.51-2.4%$0.54$0.38▼$1.79$18.35M0.8617.94 million shs869,036 shsPOAIPredictive Oncology$4.68-20.0%$3.94$0.71▼$16.54$15.88M1.35473,545 shs441,020 shsRVPRetractable Technologies$0.68+1.6%$0.68$0.60▼$1.14$20.39M1.2559,569 shs99,582 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTCYBiotricity-11.53%-32.70%-31.01%-35.00%-65.92%OSRHOSR-8.30%-7.94%-8.30%+13.73%-55.32%POAIPredictive Oncology0.00%+3.17%+66.19%+139.75%-63.89%RVPRetractable Technologies+4.69%-1.96%0.00%-5.90%-6.94%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTCYBiotricity 0.00N/AN/AN/AOSRHOSR 1.00SellN/AN/APOAIPredictive Oncology 1.00SellN/AN/ARVPRetractable Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BTCY, POAI, OSRH, and RVP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2026OSRHOSR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 5/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTCYBiotricity$12.06M0.38N/AN/A($1.30) per share-0.12OSRHOSR$2.91M6.15N/AN/A$3.63 per share0.14POAIPredictive Oncology$1.66M9.54N/AN/A($0.46) per share-10.17RVPRetractable Technologies$38.27M0.53$0.01 per share48.25$3.31 per share0.21Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTCYBiotricity-$14.09M-$0.16N/AN/AN/A-80.42%N/A-188.47%6/26/2026 (Estimated)OSRHOSR-$27.06M-$0.33N/AN/AN/A-363.26%-7.24%-5.41%N/APOAIPredictive Oncology-$12.66M-$13.50N/AN/AN/A-5,065.23%-732.73%-235.55%N/ARVPRetractable Technologies-$7.01M-$0.21N/AN/AN/A-41.11%-17.15%-9.33%N/ALatest BTCY, POAI, OSRH, and RVP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026OSRHOSRN/A-$0.09N/A-$0.09N/A$0.48 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBTCYBiotricityN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/APOAIPredictive OncologyN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTCYBiotricityN/A0.230.10OSRHOSRN/A0.160.14POAIPredictive OncologyN/A0.010.01RVPRetractable Technologies0.018.575.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTCYBiotricity3.89%OSRHOSR55.30%POAIPredictive Oncology9.04%RVPRetractable Technologies7.58%Insider OwnershipCompanyInsider OwnershipBTCYBiotricity10.10%OSRHOSR60.60%POAIPredictive Oncology1.21%RVPRetractable Technologies59.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTCYBiotricity4028.60 million22.08 millionNo DataOSRHOSRN/A35.10 million13.83 millionN/APOAIPredictive Oncology303.39 million3.35 millionNot OptionableRVPRetractable Technologies24029.94 million13.47 millionOptionableBTCY, POAI, OSRH, and RVP HeadlinesRecent News About These CompaniesRetractable Technologies, Inc. Results for the Period Ended March 31, 2026May 15, 2026 | businesswire.comRetractable Technologies Shareholders Reelect Class 2 DirectorsMay 13, 2026 | tipranks.comCritical Survey: Retractable Technologies (NYSE:RVP) & Interpace Biosciences (OTCMKTS:IDXG)May 12, 2026 | americanbankingnews.comRetractable Technologies, Inc. Announces Workforce ReductionApril 9, 2026 | businesswire.comRetractable Technologies Analyst Ratings and Price Targets | AMEX:RVP | BenzingaApril 9, 2026 | benzinga.comRVP Stock Plunges Post Q4 Earnings Despite Revenue GrowthApril 1, 2026 | zacks.comRetractable Technologies Declares Preferred Dividend Amid Tariff PressuresMarch 27, 2026 | tipranks.comRetractable Technologies: Q4 Earnings SnapshotMarch 27, 2026 | houstonchronicle.comHRetractable Technologies, Inc. Reports Results for 2025March 27, 2026 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersMarch 27, 2026 | businesswire.comRVP Stock Rises Post Q3 Earnings Despite Tariff and Cost PressuresNovember 20, 2025 | zacks.comRetractable Technologies, Inc. Results for the Periods Ended September 30, 2025November 14, 2025 | businesswire.comRetractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with NeedleNovember 14, 2025 | businesswire.comRetractable Technologies (NYSE:RVP) CEO Thomas Shaw Purchases 15,000 SharesNovember 1, 2025 | insidertrades.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Acquires 35,000 Shares of StockOctober 30, 2025 | insidertrades.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Buys 34,506 Shares of StockOctober 29, 2025 | insidertrades.comRetractable Technologies (NYSE:RVP) CEO Acquires $13,209.72 in StockOctober 16, 2025 | insidertrades.comRetractable Technologies (NYSE:RVP) CEO Thomas Shaw Buys 30,000 SharesOctober 10, 2025 | insidertrades.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersSeptember 30, 2025 | businesswire.comThomas Shaw Purchases 17,500 Shares of Retractable Technologies (NYSE:RVP) StockSeptember 26, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBTCY, POAI, OSRH, and RVP Company DescriptionsBiotricity NASDAQ:BTCY$0.16 -0.02 (-8.81%) As of 03:48 PM EasternBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.OSR NASDAQ:OSRH$0.51 -0.01 (-2.45%) Closing price 04:00 PM EasternExtended Trading$0.51 0.00 (-0.57%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.Predictive Oncology NASDAQ:POAI$4.68 -1.17 (-20.00%) As of 05/18/2026Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.Retractable Technologies NYSE:RVP$0.68 +0.01 (+1.64%) Closing price 03:58 PM EasternExtended Trading$0.68 0.00 (0.00%) As of 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas HIVE Weaponizes Power for an AI Pivot Why Home Depot’s Sell-Off Could Become a Huge Opportunity Brady Corp Wires Up a Massive AI-Powered Breakout AAPL: Forget the iPhone—Services Will Drive the Next Phase of Growth Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings A Deep Dive Into NVIDIA’s Latest Portfolio Moves The $132 Billion Infrastructure Pivot You Might Have Missed The Pentagon's AI Pivot Supercharges Defense Stocks Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
